Yang Lili, Zhang Xiaogang. Mechanism of embolism in patients with dilated cardiomyopathy and progress on its prevention and treatment. [J]. Journal of Chongqing Medical University 42(5):613-617(2017)
DOI:
Yang Lili, Zhang Xiaogang. Mechanism of embolism in patients with dilated cardiomyopathy and progress on its prevention and treatment. [J]. Journal of Chongqing Medical University 42(5):613-617(2017) DOI: 10.13406/j.cnki.cyxb.001202.
Mechanism of embolism in patients with dilated cardiomyopathy and progress on its prevention and treatment
Patients with dilated cardiomyopathy(DCM)have higher incidence of heart lumen thrombosis and clinical thromboembolic events. Heart lumen thrombosis relates to many factors
including cardiac dilatation
the endocardial surface change
myocardial motion decreases
blood flow congestion
arrhythmia
blood high condensation state
etc. Now
the expert advice for adding anticoagulant therapy for patients with DCM is:left ventricular ejection fraction<30%
having a history of embolism performance
or mural thrombus formation in echocardiography. There were articles reported using aspirin
or by a combination of aspirin and hirudin drugs as conventional treatment for patients with cardiomegaly;some reported adding warfarin or new oral anticoagulants if cardiomegaly complicated with atrial fibrillation. This article reviewed the epidemiology
mechanism and prevention and cure for risk patients with DCM.